Screener
Maravai LifeSciences Holdings, Inc. MRVI Goodwill impairment
Goodwill impairment at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.
The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001823239-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Selling, general and administrative | 32,070 | 38,715 | 61,162 | 78,279 |
| Research and development | 3,702 | 4,882 | 7,591 | 9,770 |
| Goodwill impairment | — | 30,449 | — | 42,884 |
| Restructuring | (33) | — | 2,845 | — |
| Total operating expenses | 35,739 | 74,046 | 71,598 | 130,933 |
| Loss from operations | (15,089) | (66,278) | (17,247) | (115,440) |
| Other income (expense): |
Item 1. Financial Statements
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s goodwill impairment?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported goodwill impairment of $0 in Q2 2026.
- How has Maravai LifeSciences Holdings, Inc.'s goodwill impairment changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s goodwill impairment decreased by 100.0% year-over-year, from $30.45M to $0.
- What does goodwill impairment mean?
- Write-down of goodwill carrying value when a reporting unit's fair value falls below its book value, indicating that past acquisitions have lost value.
Ask your AI about Maravai LifeSciences Holdings, Inc.'s goodwill impairment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude